Abstract

Aim To clarify the contributions of fasting glucose (FG) and postprandial glucose (PG) to HbA1c in drug-naïve patients with type 2 diabetes (T2D) and impaired glucose tolerate (IGT)/impaired fasting glucose (IFG). Methods Continuous glucose monitoring (CGM) was performed in 305 drug-naïve Chinese patients with T2D or IGT/IFG. The incremental area under the curve (AUC) above a glucose value of 6.1 mmol/L or FG glucose levels were calculated to evaluate the contributions of PG or FG to HbA1c values. Results According to quintiles of HbA1c, T2D patients were divided into five groups (group 1 to 5), and patients with IGT/IFG were assigned into group 0. PG was the predominant contributor in the lower groups with HbA1c 4.9∼6.0% and 6.1∼7.8%. The relative contributions of FG and PG to HbA1c had no significance in the middle groups of HbA1c (7.9∼8.7% and 8.8∼9.5%). FG contributed significantly more than PG in the higher groups of HbA1c (9.6∼10.9% and 11.0∼14.6%). Regression analyses indicate that the contributions of FG and PG were equal (both 50%) when the level of HbA1c was 8.5%. Conclusions In drug-naïve patients with T2D or IGT/IFG, PG contributed more in patients with HbA1c < 8.5%, whereas FG became the predominant contributor in the poorly controlled patients with HbA1c ≥ 8.5%. These results may help the health-care provider set appropriate plasma glucose testing goals with the expectation of achieving specific HbA1c values.

Highlights

  • Glycemic control is a cornerstone in delaying the onset and decreasing the incidence of both the short- and long-term complications of diabetes

  • We evaluate the contribution of Fasting glucose (FG) and postprandial glucose (PG) on HbA1c in newly diagnosed and untreated patients with type 2 diabetes (T2D) or Impaired Glucose Tolerance (IGT)/Impaired Fasting Glycaemia (IFG)

  • According to quintiles of HbA1c, the subjects with diabetes were divided into five groups and patients with IGT/IFG were allocated into group 0 to evaluate the contribution of FG and PG to glucose increments

Read more

Summary

Research Article

Aim. To clarify the contributions of fasting glucose (FG) and postprandial glucose (PG) to HbA1c in drug-naıve patients with type 2 diabetes (T2D) and impaired glucose tolerate (IGT)/impaired fasting glucose (IFG). Continuous glucose monitoring (CGM) was performed in 305 drug-naıve Chinese patients with T2D or IGT/IFG. PG was the predominant contributor in the lower groups with HbA1c 4.9∼6.0% and 6.1∼7.8%. E relative contributions of FG and PG to HbA1c had no significance in the middle groups of HbA1c (7.9∼8.7% and 8.8∼9.5%). In drug-naıve patients with T2D or IGT/IFG, PG contributed more in patients with HbA1c < 8.5%, whereas FG became the predominant contributor in the poorly controlled patients with HbA1c ≥ 8.5%. Ese results may help the health-care provider set appropriate plasma glucose testing goals with the expectation of achieving specific HbA1c values In drug-naıve patients with T2D or IGT/IFG, PG contributed more in patients with HbA1c < 8.5%, whereas FG became the predominant contributor in the poorly controlled patients with HbA1c ≥ 8.5%. ese results may help the health-care provider set appropriate plasma glucose testing goals with the expectation of achieving specific HbA1c values

Introduction
Materials and Methods
AUCPG AUCFG AUCtotal
Disclosure
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call